RASHAWN JACKSON: Open Payments
NPI 1518612373 · WYANDOTTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,695 in 132 payments from 19 companies in 2025. Trend: 2023 $1,499 · 2024 $2,209 · 2025 $2,695
Food & beverage: $2,573Education: $123
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $399 |
| ABBVIE INC. | 22 | $330 |
| Regeneron Healthcare Solutions, Inc. | 14 | $324 |
| Janssen Biotech, Inc. | 9 | $256 |
| GENZYME CORPORATION | 10 | $242 |
| Galderma Laboratories, L.P. | 15 | $228 |
| Novartis Pharmaceuticals Corporation | 10 | $195 |
| PFIZER INC. | 8 | $139 |
| Amgen Inc. | 7 | $110 |
| Lilly USA, LLC | 4 | $81 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, TREMFYA, NEMLUVIO, COSENTYX, CIBINQO, OTEZLA.
Industry payments across MI — which companies pay providers there.
